Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mei‑Xiao Zhan"'
Autor:
Qing-Feng Xiang, Mei-Xiao Zhan, Yong Li, Hui Liang, Cong Hu, Yao-Ming Huang, Jing Xiao, Xu He, Yong-Jie Xin, Min-Shan Chen, Li-Gong Lu
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 83-89 (2019)
Sorafenib is an oral multikinase inhibitor that has become an established therapeutic approach in advanced hepatocellular carcinoma (HCC). However, the benefit of sorafenib in clinical therapy is often affected by drug resistance. Therefore, it is im
Externí odkaz:
https://doaj.org/article/3ce1e71681d14eef8d264373ee7d1d9c
Autor:
Li-Gong Lu, Zhi-Ling Zhou, Xu-Yan Wang, Bo-Yuan Liu, Jin-Ying Lu, Shuai Liu, Guang-Bo Zhang, Mei-Xiao Zhan, Yun Chen
Publikováno v:
Gut. 71:2551-2560
ObjectivePatients with increased PD-L1+host cells in tumours are more potent to benefit from antiprogrammed death-1/programmed death ligand-1 (PD-L1) treatment, but the underlying mechanism is still unclear. We aim to elucidate the nature, regulation
Autor:
Ligong Lu, Xu He, Yong Jie Xin, Jing Xiao, Yao Ming Huang, Mei Xiao Zhan, Hui Liang, Cong Hu, Yong Li, Min Shan Chen, Qing Feng Xiang
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology. 47:83-89
Sorafenib is an oral multikinase inhibitor that has become an established therapeutic approach in advanced hepatocellular carcinoma (HCC). However, the benefit of sorafenib in clinical therapy is often affected by drug resistance. Therefore, it is im
Autor:
Yin-Chu, Ma, Xin-Feng, Tang, You-Cui, Xu, Wei, Jiang, Yong-Jie, Xin, Wei, Zhao, Xu, He, Li-Gong, Lu, Mei-Xiao, Zhan
Publikováno v:
Biomaterials science. 9(9)
The combination of chemotherapy and radiotherapy (chemoradiotherapy) is a promising strategy, extensively studied and applied clinically. Meanwhile, radiosensitizers play an important role in improving clinical radiotherapy therapeutic efficacy. Ther
Publikováno v:
Biochemical and Biophysical Research Communications. 484:429-434
The ubiquitin-specific protease Usp7 plays roles in multiple cellular processes through deubiquitinating and stabilizing numerous substrates, including P53, Pten and Gli. Aberrant Usp7 activity has been implicated in many disorders and tumorigenesis,
Autor:
Ying‑Ping Liu, Jian‑Hua Li, Qiong‑Hui Chen, Jian‑Hua Yuan, Ligong Lu, Zhen‑Sheng Xu, Jian‑Wang Li, Wei‑Fang Zhang, Mei Xiao Zhan, Chun‑Zhen Huang, Yong Li
Publikováno v:
Oncology Reports.
Metadherin (MTDH) is a multifunctional oncogene involved in tumor cell migration and metastasis through regulating a number of oncogenic signaling pathways in various human malignancies. Previous studies have demonstrated that MTDH is overexpressed i
Autor:
Li-Gong Lu, Zhen-Sheng Xu, Jian-Hua Li, Yong Li, Jian-Wang Li, Chun-Zhen Huang, Wei-Fang Zhang, Jian-Hua Yuan, Qiong-Hui Chen, Ying-Ping Liu, Mei-Xiao Zhan
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 104
This work aims to study the roles and related mechanisms of six2 in 5-FU sensitivity of hepatocellular carcinoma (HCC) cells. KM-Plotter analysis showed that HCC patients with higher six2 expression levels had shorter overall survival. Six2 expressio
Publikováno v:
Oncology Letters
The aim of the present study was to investigate the prognostic potential of a novel inflammation-based system, the combination of the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) (CNP), for predicting the survival t
Autor:
Sirui Fu, Bao-Shan Hu, He Xu, You-Bing Zheng, Yan Zhao, Wei Zhao, Jian-Wen Huang, Li Yong, Ligong Lu, Bing Liu, Mei-Xiao Zhan
Publikováno v:
Medical Oncology. 31
Kinase insert domain receptor (KDR) is the principal receptor that promotes the pro-angiogenic action of vascular endothelial growth factor and has been the principal target of anti-angiogenic therapies. Our aim was to determine whether single-nucleo
Autor:
Ligong Lu, Bao-shan Hu, Mei-Xiao Zhan, Xu He, You-bing Zheng, Wei Zhao, Jian-Wen Huang, Bing Liu, Yong Li
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 35(11)
Kinase insert domain receptor (KDR) is the principal receptor that promotes the proangiogenic action of vascular endothelial growth factor and is involved in the tumorigenesis and progression of many malignancies, including hepatocellular carcinoma (